BioCatalyst

Emicizumab — catalyst calendar

1 verified catalyst event(s) referencing Emicizumab, each linked to its official source. Verified as of 2026-10-24.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-11-19
in 26d
ESTIMATED
 READOUT
A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Par
Phase 4 · Severe Hemophilia A, Moderate Hemophilia A
 Hoffmann-La Roche Emicizumab ClinicalTrials.gov ↗
✓ Source-checked 2026-10-24
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.